Search | Page 21 | Aplastic Anemia and MDS International Foundation


Search results

  1. MDS and MDS/MPN: Past, Present, and Future 2014 American Society of Hematology (ASH) Satellite Symposium Summary for Patients and Families

    ... JMML, or aCML; includes the provisional category of refractory anemia with ringed sideroblasts associated with marked ...

    Page last updated 03/13/2015 - 5:00pm.

  2. Interviews with the Experts Pioneering Quality of Life Research for MDS Patients

    ... around 40% of patients on the NIH trial who were refractory to immunosuppression did have a response to eltrombopag, whether ...

    Interview last updated 04/03/2014 - 2:13pm.

  3. An Open-label Study of Lirilumab (BMS-986015) in Combination With 5-azacytidine (Vidaza) for the Treatment of Patients With Refractory/ Relapsed Acute Myeloid Leukemia

    For more details on this clinical trial, including contact information, please see this trial’s listing on ...

    Clinical Trial last updated 06/06/2016 - 1:26pm.

  4. Veteran Patients

    ... MDS-related terminology, including “preleukemia” or “refractory anemia” (see my related  Beacon  column), may be contributing ...

    Topic section last updated 03/25/2016 - 11:56am.

  5. Agent Orange, United States Military Veterans, and Myelodysplastic Syndromes

    ... MDS-related terminology, including “preleukemia” or “refractory anemia” (see my related Beacon column), may be contributing ...

    Page last updated 12/19/2013 - 10:58am.